Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
- PMID: 10976635
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype
Abstract
Brain metabolism and the activity of the alpha-ketoglutarate dehydrogenase complex (KGDHC), a mitochondrial enzyme, are diminished in brains from patients with Alzheimer's disease (AD). In 109 subjects, the Clinical Dementia Rating (CDR) score was highly correlated with brain KGDHC activity. In AD patients who carried the epsilon 4 allele of the apolipoprotein E gene (ApoE4), the CDR score correlated better with KGDHC activity than with the densities of neuritic plaques or neuritic tangles. In contrast, in patients without ApoE4, the CDR score correlated significantly better with tangles and plaques than with KGDHC activity. The results suggest that mitochondrial/oxidative damage may be more important for the cognitive dysfunction in AD patients who carry ApoE4 than in those who do not.
Similar articles
-
Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease.Neurobiol Dis. 2006 Feb;21(2):256-75. doi: 10.1016/j.nbd.2005.07.004. Epub 2005 Sep 29. Neurobiol Dis. 2006. PMID: 16198584
-
A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.Neurobiol Aging. 2004 Sep;25(8):1017-22. doi: 10.1016/j.neurobiolaging.2003.11.002. Neurobiol Aging. 2004. PMID: 15212826
-
Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.Brain. 2008 May;131(Pt 5):1252-8. doi: 10.1093/brain/awn034. Epub 2008 Mar 11. Brain. 2008. PMID: 18334538
-
ApoE genotype accounts for the vast majority of AD risk and AD pathology.Neurobiol Aging. 2004 May-Jun;25(5):641-50. doi: 10.1016/j.neurobiolaging.2003.12.023. Neurobiol Aging. 2004. PMID: 15172743 Review.
-
Apolipoprotein E and Alzheimer's disease.Annu Rev Neurosci. 1996;19:53-77. doi: 10.1146/annurev.ne.19.030196.000413. Annu Rev Neurosci. 1996. PMID: 8833436 Review.
Cited by
-
Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases.Biomolecules. 2023 Dec 13;13(12):1789. doi: 10.3390/biom13121789. Biomolecules. 2023. PMID: 38136659 Free PMC article. Review.
-
Apolipoprotein E in Alzheimer's Disease: Focus on Synaptic Function and Therapeutic Strategy.Mol Neurobiol. 2025 Mar;62(3):3040-3052. doi: 10.1007/s12035-024-04449-1. Epub 2024 Aug 31. Mol Neurobiol. 2025. PMID: 39214953 Review.
-
Genetics of Alzheimer disease.J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. doi: 10.1177/0891988710383571. J Geriatr Psychiatry Neurol. 2010. PMID: 21045163 Free PMC article. Review.
-
Deficits in the mitochondrial enzyme α-ketoglutarate dehydrogenase lead to Alzheimer's disease-like calcium dysregulation.Neurobiol Aging. 2012 Jun;33(6):1121.e13-24. doi: 10.1016/j.neurobiolaging.2011.11.003. Epub 2011 Dec 14. Neurobiol Aging. 2012. PMID: 22169199 Free PMC article.
-
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.Pharmaceuticals (Basel). 2009 Dec 23;2(3):250-286. doi: 10.3390/ph2030250. Pharmaceuticals (Basel). 2009. PMID: 27713238 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical